mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.003 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.005 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.007 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.007 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.007 |